Blueprint Medicines Receives Positive CHMP Opinion for Avapritinib for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors July 24, 2020
Adaptimmune Granted Access to PRIority MEdicines (PRIME) Regulatory Support by the European Medicines Agency for ADP-A2M4 for the Treatment of Synovial Sarcoma July 23, 2020
Interos and RiskRecon Identify Vulnerable and Hidden Third, Fourth, and Fifth Party Suppliers July 22, 2020
Ultragenyx Announces U.S. Commercial Launch of Dojolvi™ (triheptanoin), the First FDA-Approved Therapy for the Treatment of Long-chain Fatty Acid Oxidation Disorders July 22, 2020
Flywire Helps Education Agents and Institutions Streamline International Tuition Payments July 21, 2020
Everest Group Recognizes Whatfix as a Leader in Digital Adoption Platforms PEAK Matrix Report 2020 July 21, 2020
Orchard Therapeutics Announces Orphan Drug and Rare Pediatric Disease Designations for OTL-203 for the Treatment of MPS-I July 21, 2020